Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides-Reference-Cited by-同舟云学术

Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides

Published:2018-06-05 Issue:6 Volume:13 Page:e0198478
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tintori Cristina,Iovenitti Giulia,Ceresola Elisa Rita,Ferrarese Roberto,Zamperini Claudio,Brai Annalaura,Poli Giulio,Dreassi Elena,Cagno Valeria,Lembo David,Canducci Filippo,Botta Maurizio^ORCID

Funder

European Union FP7-HEALTH

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Global health sector strategy on sexually transmitted infections 2016–2021,2016

2. After CAPRISA 004: time to re-evaluate the HIV lexicon;W Jr Cates;Lancet,2010

3. The North Carolina contribution to the CAPRISA 004 study: the Global Health Initiative in action;W Jr Cates;N C Med J,2010

4. Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial;QA Karim;Trials,2011

5. CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck;Z Valley-Omar;J Infect Dis,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CB‐0821, a novel CC chemokine receptor 5 (CCR5) inhibitor with improved binding efficacy proposed as anti‐HIV candidate: Computational and in vitro approach;Biotechnology and Applied Biochemistry;2024-03-31

2. Therapeutic potentials of N‐acetylcysteine immobilized polyrhodanine nanoparticles toward acetaminophen‐induced acute hepatotoxicity in rat;Chemical Biology & Drug Design;2023-12-28

3. Thiazolidin-4-Ones as a Promising Scaffold in the Development of Antibiofilm Agents—A Review;International Journal of Molecular Sciences;2023-12-26

4. Strategic actions to advance multipurpose prevention technologies in low- and middle-income countries;Frontiers in Reproductive Health;2023-07-03

5. Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors;Archiv der Pharmazie;2023-06-30